Pulmonary	pulmonary	O	O	O	O
shunt	shunt	O	O	O	O
and	and	O	O	O	O
cardiovascular	cardiovascular	O	O	O	O
responses	responses	O	O	O	O
to	to	O	O	O	O
CPAP	cpap	O	O	O	O
during	during	O	O	O	O
nitroprusside-induced	nitroprusside-induced	O	O	O	O
hypotension	hypotension	O	DISEASE	OTHERS	I
.	.	O	O	O	O

The	the	O	O	O	O
effects	effects	O	O	O	O
of	of	O	O	O	O
continuous	continuous	O	O	O	O
positive	positive	O	O	O	O
airway	airway	O	O	O	O
pressure	pressure	O	O	O	O
(	(	O	O	O	O
CPAP	cpap	O	O	O	O
)	)	O	O	O	O
on	on	O	O	O	O
cardiovascular	cardiovascular	O	O	O	O
dynamics	dynamics	O	O	O	O
and	and	O	O	O	O
pulmonary	pulmonary	O	O	O	O
shunt	shunt	O	O	O	O
(	(	O	O	O	O
QS/QT	qs/qt	O	O	O	O
)	)	O	O	O	O
were	were	O	O	O	O
investigated	investigated	O	O	O	O
in	in	O	O	O	O
12	12	O	O	O	O
dogs	dogs	O	O	O	O
before	before	O	O	O	O
and	and	O	O	O	O
during	during	O	O	O	O
sodium	sodium	CHEMICALS	O	OTHERS	I
nitroprusside	nitroprusside	CHEMICALS	O	OTHERS	I
infusion	infusion	O	O	O	O
that	that	O	O	O	O
decreased	decreased	O	O	O	O
mean	mean	O	O	O	O
arterial	arterial	O	O	O	O
blood	blood	O	O	O	O
pressure	pressure	O	O	O	O
40	40	O	O	O	O
-	-	O	O	O	O
50	50	O	O	O	O
per	per	O	O	O	O
cent	cent	O	O	O	O
.	.	O	O	O	O

Before	before	O	O	O	O
nitroprusside	nitroprusside	CHEMICALS	O	OTHERS	I
infusion	infusion	O	O	O	O
,	,	O	O	O	O
5	5	O	O	O	O
cm	cm	O	DISEASE	OTHERS	I
H2O	h2o	CHEMICALS	O	OTHERS	I
CPAP	cpap	O	O	O	O
significantly	significantly	O	O	O	O
,	,	O	O	O	O
P	p	O	O	OTHERS	I
less	less	O	O	O	O
than	than	O	O	O	O
.05	.05	O	O	O	O
,	,	O	O	O	O
decreased	decreased	O	O	O	O
arterial	arterial	O	O	O	O
blood	blood	O	O	O	O
pressure	pressure	O	O	O	O
,	,	O	O	O	O
but	but	O	O	O	O
did	did	O	O	O	O
not	not	O	O	O	O
significantly	significantly	O	O	O	O
alter	alter	O	O	O	O
heart	heart	O	O	O	O
rate	rate	O	O	O	O
,	,	O	O	O	O
cardiac	cardiac	O	O	O	O
output	output	O	O	O	O
,	,	O	O	O	O
systemic	systemic	O	O	O	O
vascular	vascular	O	O	O	O
resistance	resistance	O	O	O	O
,	,	O	O	O	O
or	or	O	O	O	O
QS/QT	qs/qt	O	O	O	O
.	.	O	O	O	O

Ten	ten	O	O	O	O
cm	cm	O	DISEASE	OTHERS	I
H2O	h2o	CHEMICALS	O	OTHERS	I
CPAP	cpap	O	O	O	O
before	before	O	O	O	O
nitroprusside	nitroprusside	CHEMICALS	O	OTHERS	I
infusion	infusion	O	O	O	O
produced	produced	O	O	O	O
a	a	O	O	O	O
further	further	O	O	O	O
decrease	decrease	O	O	OTHERS	I
in	in	O	O	OTHERS	I
arterial	arterial	O	O	OTHERS	I
blood	blood	O	O	OTHERS	I
pressure	pressure	O	O	OTHERS	I
and	and	O	O	O	O
significantly	significantly	O	O	O	O
increased	increased	O	O	O	O
heart	heart	O	O	O	O
rate	rate	O	O	O	O
and	and	O	O	O	O
decreased	decreased	O	O	OTHERS	I
cardiac	cardiac	O	O	OTHERS	I
output	output	O	O	OTHERS	I
and	and	O	O	O	O
QS/QT	qs/qt	O	O	O	O
.	.	O	O	O	O

Nitroprusside	nitroprusside	CHEMICALS	O	OTHERS	I
caused	caused	O	O	O	O
significant	significant	O	O	O	O
decreases	decreases	O	O	OTHERS	I
in	in	O	O	OTHERS	I
arterial	arterial	O	O	OTHERS	I
blood	blood	O	O	OTHERS	I
pressure	pressure	O	O	OTHERS	I
and	and	O	O	O	O
systemic	systemic	O	O	O	O
vascular	vascular	O	O	O	O
resistance	resistance	O	O	O	O
and	and	O	O	O	O
increases	increases	O	O	O	O
in	in	O	O	O	O
heart	heart	O	O	O	O
rate	rate	O	O	O	O
,	,	O	O	O	O
but	but	O	O	O	O
did	did	O	O	O	O
not	not	O	O	O	O
change	change	O	O	O	O
cardiac	cardiac	O	O	O	O
output	output	O	O	O	O
or	or	O	O	O	O
QS/QT	qs/qt	O	O	O	O
.	.	O	O	O	O

Five	five	O	O	O	O
cm	cm	O	DISEASE	OTHERS	I
H2O	h2o	CHEMICALS	O	OTHERS	I
CPAP	cpap	O	O	O	O
during	during	O	O	O	O
nitroprusside	nitroprusside	CHEMICALS	O	OTHERS	I
did	did	O	O	O	O
not	not	O	O	O	O
further	further	O	O	O	O
alter	alter	O	O	O	O
any	any	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
above-mentioned	above-mentioned	O	O	O	O
variables	variables	O	O	O	O
.	.	O	O	O	O

However	however	O	O	O	O
,	,	O	O	O	O
10	10	O	O	O	O
cm	cm	O	DISEASE	OTHERS	I
H2O	h2o	CHEMICALS	O	OTHERS	I
CPAP	cpap	O	O	O	O
decreased	decreased	O	O	O	O
arterial	arterial	O	O	O	O
blood	blood	O	O	O	O
pressure	pressure	O	O	O	O
,	,	O	O	O	O
cardiac	cardiac	O	O	O	O
output	output	O	O	O	O
,	,	O	O	O	O
and	and	O	O	O	O
QS/QT	qs/qt	O	O	O	O
.	.	O	O	O	O

These	these	O	O	O	O
data	data	O	O	O	O
indicate	indicate	O	O	O	O
that	that	O	O	O	O
nitroprusside	nitroprusside	CHEMICALS	O	OTHERS	I
infusion	infusion	O	O	O	O
rates	rates	O	O	O	O
that	that	O	O	O	O
decrease	decrease	O	O	O	O
mean	mean	O	O	O	O
arterial	arterial	O	O	O	O
blood	blood	O	O	O	O
pressure	pressure	O	O	O	O
by	by	O	O	O	O
40	40	O	O	O	O
-	-	O	O	O	O
50	50	O	O	O	O
per	per	O	O	O	O
cent	cent	O	O	O	O
do	do	O	O	O	O
not	not	O	O	O	O
change	change	O	O	O	O
cardiac	cardiac	O	O	O	O
output	output	O	O	O	O
or	or	O	O	O	O
QS/QT	qs/qt	O	O	O	O
.	.	O	O	O	O

During	during	O	O	O	O
nitroprusside	nitroprusside	CHEMICALS	O	OTHERS	I
infusion	infusion	O	O	O	O
low	low	O	O	O	O
levels	levels	O	O	O	O
of	of	O	O	O	O
CPAP	cpap	O	O	O	O
do	do	O	O	O	O
not	not	O	O	O	O
markedly	markedly	O	O	O	O
alter	alter	O	O	O	O
cardiovascular	cardiovascular	O	O	O	O
dynamics	dynamics	O	O	O	O
,	,	O	O	O	O
but	but	O	O	O	O
high	high	O	O	O	O
levels	levels	O	O	O	O
of	of	O	O	O	O
CPAP	cpap	O	O	O	O
(	(	O	O	O	O
10	10	O	O	O	O
cm	cm	O	DISEASE	OTHERS	I
H2O	h2o	CHEMICALS	O	OTHERS	I
)	)	O	O	O	O
,	,	O	O	O	O
while	while	O	O	O	O
decreasing	decreasing	O	O	O	O
QS/QT	qs/qt	O	O	O	O
,	,	O	O	O	O
produce	produce	O	O	O	O
marked	marked	O	O	O	O
decreases	decreases	O	O	OTHERS	I
in	in	O	O	OTHERS	I
arterial	arterial	O	O	OTHERS	I
blood	blood	O	O	OTHERS	I
pressure	pressure	O	O	OTHERS	I
and	and	O	O	O	O
cardiac	cardiac	O	O	O	O
output	output	O	O	O	O
.	.	O	O	O	O

